New cancer-fighting drugs could emerge from The University of Queensland in coming years, thanks to a state-of-the-art imaging facility opened on March 28th at Brisbane, Queensland, Australia.
A $2.5 million grant from the Australian Cancer Research Foundation (ACRF) enabled the purchase of a large-bore PET-CT scanner and an upgrade of the centre’s existing Magnetic Resonance Imaging (MRI) facilities. The new ACRF Facility for Molecular Imaging Agents in Cancer is housed in UQ’s Centre for Advanced Imaging (CAI).
CAI director Professor David Reutens said the facility’s opening today would enable “a new paradigm” in comparative oncology by allowing researchers to examine the effects of tiny doses of anti-cancer drugs in both human and animal cancers at a cellular level.
“We are using molecular imaging to improve cancer detection, characterisation, treatment and monitoring. The new facility addresses a key issue in enhancing the success of clinical trials on human cancer therapies. Researchers will use naturally occurring cancers in companion animals such as dogs to bridge the gap between conventional preclinical models and human trials, facilitating clinical translation of new drugs, devices, and imaging procedures for human cancers,” Professor Reutens said.
Australian Cancer Research Foundation CEO Professor Ian Brown said the ACRF Facility for Molecular Imaging Agents in Cancer offered a new opportunity to better understand cancer in its many forms.
“It provides a chance for the development of new approaches for the prevention, detection and treatment of cancer,” said Professor Ian Brown . The ACRF supporters who made this grant possible know that the investment in state-of-the-art technology when placed in the hands of the best researchers will lead to the breakthroughs that we all desire. The facility will build on the long-term development of world-class facilities in health and medical bioscience and research in Queensland, linking with other imaging capabilities such as the Herston Imaging Research Facility and the TRI Innovation and Translation Centre. Research and innovation are our best means of finding ways to end cancer.”